"Johnson & Johnson lost a $257.7 million jury verdict in Louisiana for making misleading claims about the safety of the company’s Risperdal antipsychotic drug.
J&J officials defrauded the state’s Medicaid system by wrongfully touting Risperdal as superior to competing antipsychotic drugs and minimizing its links to diabetes, said jurors in state court in Opelousas, Louisiana.
Yesterday’s verdict is the second trial loss in a state lawsuit brought over Risperdal marketing. A West Virginia judge in a non-jury trial last year awarded $3.95 million, finding the company misled doctors about the risks and benefits of Risperdal. New Brunswick, New Jersey-based J&J appealed."
The young woman in the wheelchair is suffering from Tardive Dyskinesia/Dystonia. That's one of Risperdal's Direct Effects.
The Unfortunate aspect of this story is that Juries are not yet fixing $257.7 Million Dollar Penalties to the Individual Doctors who prescribe Risperdal, and other antipsychotics: since the Psychiatric Industry informed the US Dept. of Health, Education & Welfare in 1976, 34 years ago, of its Abnormal Involuntary Movement (AIMS) numerical rating system which they use to assess the neurological damage they inflict with antipsychotics, ..... while allowing the manufacturers to take the $257.7 Milllion 'Slap On The Wrist'.